Immunotherapy reduces cardiovascular risk in rheumatoid arthritis

Immunotherapy reduces cardiovascular risk in patients with rheumatoid arthritis, according to new research. The combination of two extra-low dose anticytokine drugs reduced rheumatoid arthritis disease activity and cardiovascular events.